Policy & Regulations

This channel includes news coverage of healthcare policy and regulations set by Congress, the states, Centers for Disease Control and Prevention (CDC), the Department of Health and Human Services (HHS), U.S. Food and Drug Administration (FDA), and medical associations and societies. 

Thumbnail

Imaging giant RadNet earns FDA greenlight for AI-based prostate MRI software

“Quantib Prostate 3.0” offers a suite of tools to help radiologists and urologists improve the quality of their assessments.

The Nanox.ARC imaging system

Nanox shares up 63% after scoring FDA clearance for new imaging system

The Nanox.ARC utilizes novel, cold-cathode X-ray tubes and charges physicians using a “pay per scan” business model. 

cardiologist doctor physician patient black diverse hypertension

Q&A: Why the future of physician payments is looking brighter

Health Exec caught up with Claire Ernst from MGMA to learn more about the possibility of physician payments being tied to inflation in the future.

Thumbnail

Heart surgeon charged with 'professional incompetency,' harmful practices

The surgeon, who now lives in a different state, has 20 days to respond to allegations made by the Iowa Board of Medicine.

The FDFA has cleared tirzepatide (Mounjaro) from Eli Lilly for the treatment of diabetes.

Eli Lilly targets FDA approval for weight loss medication

Tirzepatide, sold under the name Mounjaro, is among a handful of drugs with big buzz for their weight loss results, and approval for obesity could be a huge revenue source for Eli Lilly in the future.

Thumbnail

American College of Radiology issues heads-up on possible payment denials at certain facility types

ACR is urging providers who encounter such denials to contact their local Medicare Administrative Contractor and consults related CMS documents. 

Thumbnail

ACR applauds FDA about-face on use of iodinated contrast in children

The update marks a change from the FDA's stance on the topic last year.

Price shopping transparency

CMS to punish hospitals sooner for price transparency noncompliance

Several studies have found that compliance is low with the government's new price transparency regulations. CMS hopes these newly announced changes can make a difference.